Funder: ALS Association
Due Dates: June 25, 2025 (Applications Open) | December 3, 2025 (Stage 1 Applications Close)
Funding Amounts: Up to £7.5 million (~$10M) total; staged awards: £100,000 (20 teams), £200,000 (10 teams), £500,000 (5 teams), £1,000,000 (final winner)
Summary: Global, multi-stage challenge to accelerate AI-driven drug discovery for ALS by identifying and validating new therapeutic targets.
Key Information: Multi-phase competition with staged funding; open to international, multidisciplinary teams.